Peking University Shenzhen Hosptal
Shenzhen, Guangdong, 518036, China
Location status: Recruiting
NCT Number: NCT04574089
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.
Interested in participating?
Request Info18 year–55 year
Female
Interventional
Phase 3
Shenzhen, Guangdong, 518036, China
Location status: Recruiting
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.
Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days.
Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days.
The efficacy and safety will be evaluated 7~14 days after treatment and 35~42 days after treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Aerobic vaginitis diagnosed based on present :
Exclusion criteria
Experimental: Baofukang Suppository 7 days
Other names: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 14 days
Other names: Baofukang Suppository 14 days
Time frame: First week after treatment
A vaginal smear composite Donders score of 1 to 2 represents normality. A score of more than 2 is aerobic vaginitis. There are four variables(Lactobacillary; leucocytes; toxic leukocytes; parabasal cells; background flora). Detail see references Links.
Time frame: First month after the treatment
A vaginal smear composite Donders score of 1 to 2 represents normality. A score of more than 2 is aerobic vaginitis. There are four variables(Lactobacillary; leucocytes; toxic leukocytes; parabasal cells; background flora).Detail see folowing references.
Time frame: First week after treatment
Number of Participants Experiencing AEs Following the First Dose of the Study Product
Contact information is provided by the study sponsor or research team.
Peking University Shenzhen Hospital
Other
Medical Ethics Committee of Peking University Shenzhen Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07607470
Bacterial Infections, Bacterial Infections and Mycoses
North Miami, Florida, United States
View Trial DetailsNCT06070454
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Charlottesville, Virginia, United States
View Trial DetailsNCT06771063
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Beijing, Beijing Municipality, China
View Trial DetailsNCT07526948
Acquired Immunodeficiency Syndrome, Aging, Premature
The Bronx, New York, United States
View Trial Details